Squarepoint’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$30K Buy
+41,058
New +$30K ﹤0.01% 2650
2024
Q3
Sell
-10,214
Closed -$17.7K 2593
2024
Q2
$17.7K Sell
10,214
-57,364
-85% -$99.2K ﹤0.01% 2424
2024
Q1
$162K Sell
67,578
-93,547
-58% -$224K ﹤0.01% 2153
2023
Q4
$537K Buy
+161,125
New +$537K ﹤0.01% 1655
2023
Q3
Sell
-285,338
Closed -$1.22M 2506
2023
Q2
$1.22M Buy
285,338
+197,489
+225% +$843K ﹤0.01% 1155
2023
Q1
$601K Buy
87,849
+54,284
+162% +$371K ﹤0.01% 1388
2022
Q4
$266K Sell
33,565
-38,946
-54% -$308K ﹤0.01% 1750
2022
Q3
$697K Buy
+72,511
New +$697K ﹤0.01% 1249
2021
Q3
Sell
-116,257
Closed -$1.61M 2293
2021
Q2
$1.61M Buy
+116,257
New +$1.61M 0.01% 914
2021
Q1
Sell
-22,254
Closed -$387K 2618
2020
Q4
$387K Buy
+22,254
New +$387K ﹤0.01% 1687
2020
Q3
Sell
-16,280
Closed -$291K 2353
2020
Q2
$291K Sell
16,280
-90,085
-85% -$1.61M ﹤0.01% 1580
2020
Q1
$1.73M Buy
106,365
+13,841
+15% +$224K 0.04% 496
2019
Q4
$1.67M Buy
92,524
+62,683
+210% +$1.13M 0.01% 994
2019
Q3
$605K Sell
29,841
-49,732
-62% -$1.01M 0.01% 1468
2019
Q2
$1.76M Buy
79,573
+4,184
+6% +$92.5K 0.02% 905
2019
Q1
$1.03M Buy
+75,389
New +$1.03M 0.01% 1090
2018
Q4
Sell
-20,780
Closed -$343K 1952
2018
Q3
$343K Buy
+20,780
New +$343K ﹤0.01% 1468
2018
Q1
Sell
-23,032
Closed -$203K 1728
2017
Q4
$203K Buy
23,032
+6,740
+41% +$59.4K ﹤0.01% 1777
2017
Q3
$217K Sell
16,292
-47,278
-74% -$630K ﹤0.01% 1329
2017
Q2
$912K Buy
63,570
+53,711
+545% +$771K 0.02% 752
2017
Q1
$209K Buy
+9,859
New +$209K 0.01% 1259
2016
Q1
Sell
-10,700
Closed -$246K 1200
2015
Q4
$246K Buy
+10,700
New +$246K 0.03% 895